OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytochrome 4Z1 Expression Is Correlated with Poor Prognosis in Patients with Cervical Cancer
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Ahmed M. M. Youssef, et al.
Current Oncology (2021) Vol. 28, Iss. 5, pp. 3573-3584
Open Access | Times Cited: 21

Showing 21 citing articles:

Phytochemistry and Anticancer Effects of Mangrove (Rhizophora mucronata Lam.) Leaves and Stems Extract against Different Cancer Cell Lines
Ahmed M. M. Youssef, Doaa A. M.‎ Maaty, Yousef M. Al-saraireh
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 4-4
Open Access | Times Cited: 29

Phytochemical Analysis and Profiling of Antitumor Compounds of Leaves and Stems of Calystegia silvatica (Kit.) Griseb.
Ahmed M. M. Youssef, Doaa A. M.‎ Maaty, Yousef M. Al-saraireh
Molecules (2023) Vol. 28, Iss. 2, pp. 630-630
Open Access | Times Cited: 18

Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers
Yi-Wen Meng, Jun‐Yan Liu
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108612-108612
Closed Access | Times Cited: 6

Phytochemical Analysis and Profiling of Antioxidants and Anticancer Compounds from Tephrosia purpurea (L.) subsp. apollinea Family Fabaceae
Ahmed M. M. Youssef, Doaa A. M.‎ Maaty, Yousef M. Al-saraireh
Molecules (2023) Vol. 28, Iss. 9, pp. 3939-3939
Open Access | Times Cited: 14

The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review
Charles Leahy, Nicholas J. Osborne, Leticia Shirota, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116241-116241
Closed Access | Times Cited: 4

The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis
Yaxuan Zhang, Lanying Li, Qingling Han, et al.
Journal of Obstetrics and Gynaecology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 2

Cytochrome P450 1B1 Overexpression in Cervical Cancers: Cross-sectional Study
Fatemah O. F. O. Alshammari, Yousef M. Al-saraireh, Ahmed M. M. Youssef, et al.
Interactive Journal of Medical Research (2021) Vol. 10, Iss. 4, pp. e31150-e31150
Open Access | Times Cited: 18

Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Omar H. Abu-azzam, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2898-2898
Open Access | Times Cited: 6

Cytochrome 4Z1 Expression is Associated with Poor Prognosis in Colon Cancer Patients
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Ahmed M. M. Youssef, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 5249-5260
Open Access | Times Cited: 15

Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Ahmed M. M. Youssef, et al.
Breast Cancer Targets and Therapy (2021) Vol. Volume 13, pp. 565-574
Open Access | Times Cited: 14

There and Back Again: A Perspective on 20 Years of CYP4Z1
John P. Kowalski, Allan E. Rettie
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 6, pp. 498-507
Open Access | Times Cited: 1

Cytochrome 4Z1 Expression Connotes Unfavorable Prognosis in Ovarian Cancers
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Anas Satari, et al.
Medicina (2022) Vol. 58, Iss. 9, pp. 1263-1263
Open Access | Times Cited: 8

Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization
Yin Yuan, Hong Yao, Manzhen Zhou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15749-15769
Closed Access | Times Cited: 7

Monitoring of autoantibodies against CYP4Z1 in patients with colon, ovarian, or prostate cancer
Christopher Khayeka–Wandabwa, Xiaoshuang Ma, Yingjie Jia, et al.
Immunobiology (2022) Vol. 227, Iss. 2, pp. 152174-152174
Closed Access | Times Cited: 6

Glypican-3 Differentiates Intraductal Carcinoma and Paget’s Disease from Other Types of Breast Cancer
Fatemah O. F. O. Alshammari, Anas Satari, Ahmed Aljabali, et al.
Medicina (2022) Vol. 59, Iss. 1, pp. 86-86
Open Access | Times Cited: 6

Targeting Cytochrome P450 Enzymes in Ovarian Cancers: new approaches for Tumour-Selective Interventions
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Omar H. Abu-azzam, et al.
(2023)
Open Access | Times Cited: 3

Prediction of prognosis and immune landscape in cervical cancer based on heat shock protein-related genes
Min Wang, Zhizun Li
International Journal of Hyperthermia (2023) Vol. 40, Iss. 1
Open Access | Times Cited: 3

Enhancement of hippocampal-dependent spatial memory by Ashwagandha ( Withania somnifera ) characterized by activation of NMDA receptors against monosodium glutamate-induced neurotoxicity in rats
Rawand H. Al-dmour, Nafe M. Al-Tawarah, Nesrin Mwafi, et al.
International Journal of Neuroscience (2023), pp. 1-9
Closed Access | Times Cited: 2

Improved methods for the detection of heme and protoporphyrin IX adducts and quantification of heme B from cytochrome P450 containing systems
Robert Pelletier, Allan E. Rettie, John P. Kowalski
Journal of Chromatography B (2023) Vol. 1231, pp. 123921-123921
Open Access | Times Cited: 2

1‐Benzylimidazole attenuates the stemness of breast cancer cells through partially targeting CYP4Z1
Hai Qin, Yi Zhou, Liu Hai, et al.
Environmental Toxicology (2023) Vol. 39, Iss. 3, pp. 1505-1520
Closed Access

Page 1

Scroll to top